sb 239063 has been researched along with Developmental Psychomotor Disorders in 1 studies
SB 239063: structure in first source
SB-239063 : A member of the class of imidazoles carrying 4-hydroxycyclohexyl, 4-fluorophenyl and 2-methoxypyrimidin-4-yl substituents at positions 1, 4 and 5 respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bison, S | 1 |
| Razzoli, M | 1 |
| Arban, R | 1 |
| Michielin, F | 1 |
| Bertani, S | 1 |
| Carboni, L | 1 |
1 other study available for sb 239063 and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
Effect of the p38 MAPK inhibitor SB-239063 on Lipopolysaccharide-induced psychomotor retardation and peripheral biomarker alterations in rats.
Topics: Animals; Biomarkers; Hormones; Imidazoles; Inflammation; Lipopolysaccharides; Male; Motor Activity; | 2011 |